Collectively, these findings suggest that the loss of DKK3 leads to TME reprogramming toward a fibrotic niche enriched with myCAFs and immunosuppressive Tregs, ultimately enhancing tumor aggressiveness. The gene discussed is DKK3; the disease is neoplasm.